These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 23233064)

  • 41. Accelerated healing of diabetic wound using artificial dermis constructed with adipose stem cells and poly (L-glutamic acid)/chitosan scaffold.
    Shen T; Pan ZG; Zhou X; Hong CY
    Chin Med J (Engl); 2013; 126(8):1498-503. PubMed ID: 23595384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
    Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
    J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poly-N-acetyl glucosamine fibers induce angiogenesis in ADP inhibitor-treated diabetic mice.
    Scherer SS; Pietramaggiori G; Matthews JC; Gennaoui A; Demcheva M; Fischer TH; Valeri CR; Orgill DP
    J Trauma; 2011 Aug; 71(2 Suppl 1):S183-6. PubMed ID: 21814116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine.
    Washimine H; Kitamura K; Ichiki Y; Yamamoto Y; Kangawa K; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1081-7. PubMed ID: 8048921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adenoviral human telomerase reverse transcriptase dramatically improves ischemic wound healing without detrimental immune response in an aged rabbit model.
    Mogford JE; Liu WR; Reid R; Chiu CP; Said H; Chen SJ; Harley CB; Mustoe TA
    Hum Gene Ther; 2006 Jun; 17(6):651-60. PubMed ID: 16776573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
    Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of Therapeutic Fever Induction in Cancer Patients Using Approved PAMP Drugs.
    Reuter URM; Oettmeier R; Hobohm U
    Transl Oncol; 2018 Apr; 11(2):330-337. PubMed ID: 29425952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving Stem and Progenitor Cell Therapeutics.
    Tamama K; McFadden K; Guan J
    Stem Cells Int; 2016; 2016():1409762. PubMed ID: 26798351
    [No Abstract]   [Full Text] [Related]  

  • 49. Adrenomedullin: Not Just Another Gastrointestinal Peptide.
    Martínez-Herrero S; Martínez A
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.
    Vázquez R; Riveiro ME; Berenguer-Daizé C; O'Kane A; Gormley J; Touzelet O; Rezai K; Bekradda M; Ouafik L
    Front Oncol; 2020; 10():589218. PubMed ID: 33489885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immuno-modulatory effect of local rhEGF treatment during tissue repair in diabetic ulcers.
    García-Honduvilla N; Cifuentes A; Ortega MA; Pastor M; Gainza G; Gainza E; Buján J; Álvarez-Mon M
    Endocr Connect; 2018 Apr; 7(4):584-594. PubMed ID: 29592858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlled drug release for tissue engineering.
    Rambhia KJ; Ma PX
    J Control Release; 2015 Dec; 219():119-128. PubMed ID: 26325405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adrenomedullin and tumour microenvironment.
    Larráyoz IM; Martínez-Herrero S; García-Sanmartín J; Ochoa-Callejero L; Martínez A
    J Transl Med; 2014 Dec; 12():339. PubMed ID: 25475159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autologous circulating angiogenic cells treated with osteopontin and delivered via a collagen scaffold enhance wound healing in the alloxan-induced diabetic rabbit ear ulcer model.
    O'Loughlin A; Kulkarni M; Vaughan EE; Creane M; Liew A; Dockery P; Pandit A; O'Brien T
    Stem Cell Res Ther; 2013; 4(6):158. PubMed ID: 24444259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiogenesis, vasculogenesis, and induction of healing in chronic wounds.
    Bauer SM; Bauer RJ; Velazquez OC
    Vasc Endovascular Surg; 2005; 39(4):293-306. PubMed ID: 16079938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular evolution of proadrenomedullin N-terminal 20 peptide (PAMP): evidence for gene co-option.
    Martínez A; Bengoechea JA; Cuttitta F
    Endocrinology; 2006 Jul; 147(7):3457-61. PubMed ID: 16574790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The angiogenesis promoter, proadrenomedullin N-terminal 20 peptide (PAMP), improves healing in both normoxic and ischemic wounds either alone or in combination with autologous stem/progenitor cells.
    García-Honduvilla N; Cifuentes A; Bellón JM; Buján J; Martínez A
    Histol Histopathol; 2013 Jan; 28(1):115-25. PubMed ID: 23233064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stromal progenitor cell therapy corrects the wound-healing defect in the ischemic rabbit ear model of chronic wound repair.
    Volk SW; Radu A; Zhang L; Liechty KW
    Wound Repair Regen; 2007; 15(5):736-47. PubMed ID: 17971020
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.